Prabhudas Lilladher has come out with its third quarter (October-December’ 21) earnings estimates for the Pharma sector. The brokerage house expects Cadila Healthcare to report net profit at Rs 544 crore up 3.2% year-on-year (up 7.5% quarter-on-quarter).
Net Sales are expected to decrease by 0.2 percent Y-o-Y (up 0.1 percent Q-o-Q) to Rs 3,788.1 crore, according to Prabhudas Lilladher.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 3.7 percent Y-o-Y (down 2.8 percent Q-o-Q) to Rs 836.4 crore.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
Read More
